Dietary intake of macronutrients and fiber in Mediterranean patients on chronic hemodialysis

Bossola, Maurizio; Leo, Alessandra; Viola, Antonella; Carlomagno, Giusy; Monteburini, Tania; Cenerelli, Stefano; Santarelli, Stefano; Boggi, R.; Miggiano, G A D; Vulpio, Carlo; Mele, Maria Cristina; Tazza, Luigi

doi:10.5301/jn.5000222

Cited by 17 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The finding of low dietary intake of n-3 PUFA in our cohort is consistent with previous studies reporting a lower intake of n-3 PUFA in the hemodialysis setting compared to the dietary guidelines for cardiovascular risk reduction [43,44]. Low dietary n-3 PUFA intake is also consistent with lower energy and other nutrient intake, including protein and fiber, by hemodialysis patients as compared to recommendations for cardiovascular prevention in the general population, and renal nutrition recommendations [45e47].…”

Section: Discussionsupporting

confidence: 91%

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study

et al. 2019

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 91%

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study

et al. 2019

View full text Add to dashboard Cite

show abstract

“…A textbook describes that patients undergoing hemodialysis with 1.0 mEq/L of Mg in the dialysate and whose dietary Mg intake ranges between 200 and 300 mg/day generally maintain serum Mg levels [27]. In this study, the median dietary Mg intake was 185 mg/day (IQR: 151-213 mg/day), which was less than the RDA but approximately equal to the values in some previous reports on patients undergoing hemodialysis [20,[28][29][30][31][32]. This may be because of the limited intake of foods, such as unrefined cereal grains, legume seeds, peas, beans, and nuts, which are rich in phosphorus and potassium, and also contain plenty of Mg [33].…”

Section: Discussionmentioning

confidence: 55%

Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis

2021

View full text Add to dashboard Cite

Decreased serum magnesium levels are associated with mortality and fractures in patients with chronic kidney disease; however, there is no recommendation for Mg intake in these populations. This study used cross-sectional analysis to examine the association between Mg intake and serum Mg levels in patients undergoing hemodialysis. Sixty-one patients were included. The daily Mg intake was 185 mg (IQR: 151-203 mg), and serum Mg level was 2.4 mg/dL (IQR: 2.2-2.7 mg/dL). Multiple regression analysis showed that intake of enteral formulation by tube feeding was an independent factor associated with serum Mg level (B = 0.90 [95% confidence interval: 0.61-1.20], p < 0.01). These findings may aid in serum Mg level management through diet and enteral formulation in patients undergoing hemodialysis.

show abstract

“…Each capsule contained 360 mg of eicosapentaenoic acid and 240 mg of docosahexaenoic acid. This omega-3 dose was administered according to accepted international standards (Bossola et al 2013). Patients in the control group (group B) received 4 capsules containing paraffin oil.…”

Section: Study Design and Populationmentioning

confidence: 99%

Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis

Flores

Cortez

Tresol

et al. 2020

Appl. Physiol. Nutr. Metab.

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is an increasingly common public health problem that increases the risk of death due to cardiovascular complications by 2-3 times compared to the general population. This research concerns a prospective, randomized, double-blind study in patients with CKD undergoing hemodialysis. The participants were assigned to one of two groups: the study group (group A; 46 patients) received four capsules (2.4 g) of omega-3 fatty acids daily during the 12-week intervention, while patients in the control group (group B; 47 patients) received four capsules of paraffin oil. The patients’ general characteristics, nutritional indicators, renal disease markers and inflammatory markers (C-reactive protein, interleukin-6, interleukin-10 and tumour necrosis factor alpha) were evaluated. No differences were found between the general characteristics of the patients (P <0.05), and no differences were shown in the nutritional indicators and markers of kidney disease (P <0.05). Patients in group A showed significant decreases in levels of C-reactive protein, interleukin-6, tumour necrosis factor alpha and the interleukin-10/interleukin-6 ratio after 12 weeks of supplementation (P <0.05). Patients in group B did not show any significant changes in concentrations of inflammatory markers during the intervention (P <0.05). In conclusion, oral supplementation with omega-3 fatty acids produces a significant decrease in the concentrations of inflammation markers in patients with chronic kidney disease on hemodialysis. Novelty bullets: ●Oral supplementation with omega-3 fatty acids produced significant decreases in the concentrations of inflammation markers. ●This supplementation could be given to patients with uremic syndrome and coronary heart disease to reduce cardiovascular risk.

show abstract

Dietary intake of macronutrients and fiber in Mediterranean patients on chronic hemodialysis

Abstract: In HD patients from a Mediterranean country (Italy), daily intakes of calories, proteins and fiber were lower than the recommended values, whereas the intake of lipids was closer to being adequate.

Cited by 17 publications

References 0 publications

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study

Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis

Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis

Contact Info

Product

Resources

About